Table 7.
Recommendations for the Design and Analysis of Randomized Controlled Trials Involving Longitudinal Data With Irregular Assessment
| Recommendation | Reason | Reference |
|---|---|---|
| For studies using naturalistic follow-up, include some scheduled assessments for everyone. | Improves robustness of mixed models to informative assessments | 30 |
| Measure the outcome variable at baseline. | Can study change from baseline (eliminates random intercepts) | 54 |
| Document reasons for irregularity (recommended time to next visit and whether visit is scheduled or as needed). | Reasons for irregularity can help specify a DAG. | |
| Quantify the extent of irregularity (and, in studies with protocolized visit times, include extent of irregularity in DMC reports). | Greater irregularity is associated with greater risk of bias. | 33 |
| Specify a DAG, and choose an analytic approach that is appropriate given assumed DAG. | Appropriateness of any given analytic model depends on assumptions made about interrelationships among outcomes and assessment time. | 1, 6, 16, 23 |
| Conduct sensitivity analysis. | Cannot ascertain whether the proposed DAG and model are correct; results may be sensitive to mis-specification | 1, 30, 50 |
Abbreviations: DAG, directed acyclic graph; DMC, Data Monitoring Committee.